Inhibition of Neutrophil Elastase and Cathepsin G As a New Approach to the Treatment of Psoriasis: From Fundamental Biology to Development of New...
Krasavin M. Y., Gureev M. A., Garabadzhiu A. V., Pashkin A. Y., Zhukov A. S., Khairutdinov V. R., Samtsov A. V., Shvets V. I.
Doklady Biochemistry and Biophysics
Vol.487, Issue1, P. 272-276
Опубликовано: 2019
Тип ресурса: Статья
DOI:10.1134/S1607672919040082
Аннотация:
Abstract: Psoriasis therapy remains an extremely relevant area of modern drug design, due to necessity of adverse reaction reduction, inherent for actual methods of therapy. It was established that two serine proteases—neutrophil elastase 1 (HNE1) and cathepsin G (CatG)—are the key agents in psoriasis development. The collected molecular data for the presented targets form the basis for the molecular modeling strategy for the search for and identification of new target-specific inhibitors. The result of this work is a group of high-priority small-molecule compounds with double-targeted affinity, which are able to suppress the pro-psoriatic processes induced by the considered serine proteases at the initial stage of the disease. © 2019, Pleiades Publishing, Ltd.
Ключевые слова:
cathepsin G; leukocyte elastase; serine proteinase inhibitor; chemistry; drug development; enzymology; molecular model; molecularly targeted therapy; protein conformation; psoriasis; Cathepsin G; Drug Discovery; Leukocyte Elastase; Models, Molecular; Molecular Targeted Therapy; Protein Conformation; Psoriasis; Serine Proteinase Inhibitors
Язык текста: Английский
ISSN: 1608-3091
Krasavin M. Y.
Gureev M. A. Maksim Aleksandrovich 1989-
Garabadzhiu A. V.
Pashkin A. Y.
Zhukov A. S.
Khairutdinov V. R.
Samtsov A. V.
Shvets V. I.
Красавин М. Y.
Гуреев М. А. Максим Александрович 1989-
Гарабаджиу А. В.
Пашкин А. Y.
Жуков А. С.
Хаирутдинов В. Р.
Самцов А. В.
Швец В. И.
Inhibition of Neutrophil Elastase and Cathepsin G As a New Approach to the Treatment of Psoriasis: From Fundamental Biology to Development of New Target-Specific Drugs
Inhibition of Neutrophil Elastase and Cathepsin G As a New Approach to the Treatment of Psoriasis: From Fundamental Biology to Development of New...
Текст визуальный непосредственный
Doklady Biochemistry and Biophysics
Pleiades Publishing, Ltd.
Vol.487, Issue1 P. 272-276
2019
Статья
cathepsin G leukocyte elastase serine proteinase inhibitor chemistry drug development enzymology molecular model molecularly targeted therapy protein conformation psoriasis Cathepsin G Drug Discovery Leukocyte Elastase Models, Molecular Molecular Targeted Therapy Protein Conformation Psoriasis Serine Proteinase Inhibitors
Abstract: Psoriasis therapy remains an extremely relevant area of modern drug design, due to necessity of adverse reaction reduction, inherent for actual methods of therapy. It was established that two serine proteases—neutrophil elastase 1 (HNE1) and cathepsin G (CatG)—are the key agents in psoriasis development. The collected molecular data for the presented targets form the basis for the molecular modeling strategy for the search for and identification of new target-specific inhibitors. The result of this work is a group of high-priority small-molecule compounds with double-targeted affinity, which are able to suppress the pro-psoriatic processes induced by the considered serine proteases at the initial stage of the disease. © 2019, Pleiades Publishing, Ltd.